Banyan Partners’s AbbVie ABBV Stock Holding History

Banyan Partners’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q3	$7.25M	Buy	125,470 +1,998	+2%	+$111K	0.62%	47
2014 Q2	$6.97M	Buy	123,472 +33,864	+38%	+$1.78M	0.59%	44
2014 Q1	$4.61M	Sell	89,608 -7,489	-8%	-$378K	0.4%	63
2013 Q4	$5.13M	Buy	+97,097	New	+$4.77M	0.36%	64
2013 Q3	–	Sell	-23,877	Closed	-$987K	–	339
2013 Q2	$987K	Buy	+23,877	New	+$1.04M	0.19%	109

Other funds holding ABBV

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

JHIU

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Banyan Partners's ABBV Position: Q3 2014 in Review

Banyan Partners increased its AbbVie (ABBV) stake by 1.6% in Q3 2014, buying an estimated $111K and bringing the position to 125,470 shares worth $7.25M. The position accounts for 0.62% of the portfolio, ranked #47.

Banyan Partners first reported a position in ABBV in Q2 2013 and has held it in 5 quarters since. 1,503 funds tracked by Wall St. Rank hold ABBV as of Q3 2014.

Banyan Partners held 125,470 shares of AbbVie worth $7.25M as of Q3 2014.
Banyan Partners bought 1,998 AbbVie shares in Q3 2014, an estimated $111K.
AbbVie made up 0.62% of Banyan Partners's portfolio in Q3 2014, its #47 holding.
Banyan Partners first reported a position in AbbVie in Q2 2013 and has held it in 5 quarters since.
1,503 funds tracked by Wall St. Rank held AbbVie as of Q3 2014.

Based on Banyan Partners's 13F filing for Q3 2014, filed 14 Nov 2014.